A critical discovery in cancer research is emerging with the use of VHH fragments to re-engage dysfunctional p53. This crucial cancer protector protein is frequently inactivated in various kinds of malignancies, https://bookmarkindexing.com/story21820005/nanobodies-revive-tumor-suppressor-p53-a-potential-approach-for-cancer-management